Clough Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-715
| Closed | -$509K | – | 133 |
|
|
2024
Q4 | $509K | Hold |
715
| – | – | 0.06% | 102 |
|
|
2024
Q3 | $752K | Hold |
715
| – | – | 0.08% | 106 |
|
|
2024
Q2 | $751K | Hold |
715
| – | – | 0.08% | 98 |
|
|
2024
Q1 | $688K | Hold |
715
| – | – | 0.08% | 89 |
|
|
2023
Q4 | $628K | Buy |
715
+140
| +24% | +$123K | 0.07% | 128 |
|
|
2023
Q3 | $473K | Sell |
575
-7,230
| -93% | -$5.95M | 0.05% | 135 |
|
|
2023
Q2 | $5.61M | Buy |
+7,805
| New | +$5.61M | 0.56% | 57 |
|
|
2022
Q1 | – | Sell |
-26,040
| Closed | -$16.4M | – | 138 |
|
|
2021
Q4 | $16.4M | Sell |
26,040
-6,945
| -21% | -$4.39M | 1.1% | 30 |
|
|
2021
Q3 | $20M | Sell |
32,985
-22,535
| -41% | -$13.6M | 1.21% | 28 |
|
|
2021
Q2 | $31M | Buy |
+55,520
| New | +$31M | 1.69% | 15 |
|
|
2021
Q1 | – | Sell |
-8,384
| Closed | -$4.05M | – | 158 |
|
|
2020
Q4 | $4.05M | Sell |
8,384
-14,908
| -64% | -$7.2M | 0.29% | 76 |
|
|
2020
Q3 | $13M | Sell |
23,292
-5,823
| -20% | -$3.26M | 0.94% | 37 |
|
|
2020
Q2 | $18.2M | Sell |
29,115
-8,120
| -22% | -$5.06M | 1.78% | 16 |
|
|
2020
Q1 | $18.2M | Buy |
37,235
+10,255
| +38% | +$5.01M | 1.81% | 15 |
|
|
2019
Q4 | $10.1M | Buy |
+26,980
| New | +$10.1M | 0.86% | 44 |
|